Risk factors for early intraventricular hemorrhagic complications following lateral ventricular tumor surgery.


Journal

Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181

Informations de publication

Date de publication:
07 Aug 2024
Historique:
received: 20 04 2024
accepted: 29 07 2024
revised: 19 07 2024
medline: 7 8 2024
pubmed: 7 8 2024
entrez: 6 8 2024
Statut: epublish

Résumé

The complications anticipated in the postoperative period after surgical resection of lateral ventricular neoplasms (LVN) are hemorrhage, hydrocephalus. At the N.N. Burdenko Neurosurgery Center, 48 patients with LVN underwent surgical resection. We focused on the correlation between approaches to the ventricular system on one hand and the extent of resection and incidence of complications on the other based on anatomical and perfusion characteristics estimated via preoperative magnetic resonance imaging (MRI) with arterial spin labeling perfusion. By eliminating the surgical approach as a potential risk factor, we were able to demonstrate the correlation between the frequency of postoperative hemorrhage, the Evans index value, patient's gender, tumor blood flow (nTBF) and the location of the mass in the anterior horn of the lateral ventricle. The risk of hemorrhage depends on the patient's gender, presence of hydrocephalus, location of the mass and tumor blood flow values. The risk increases along with increase in Evance index and nTBF values.

Identifiants

pubmed: 39107612
doi: 10.1007/s10143-024-02631-6
pii: 10.1007/s10143-024-02631-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

407

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Baroncini M, Peltier J, Le Gars D, Lejeune JP (2011) Tumors of the lateral ventricle. Review of 284 cases. Neurochirurgie 57(4–6):170–179. https://doi.org/10.1016/j.neuchi.2011.09.020
doi: 10.1016/j.neuchi.2011.09.020 pubmed: 22032889
Pendl G, Ozturk E, Haselsberger K (1992) Surgery of tumours of the lateral ventricle. Acta Neurochir 116:128–136. https://doi.org/10.1007/BF01540865
doi: 10.1007/BF01540865 pubmed: 1502946
D’Angelo VA, Galarza M, Catapano D, Monte V, Bisceglia M, Carosi I (2005) Lateral ventricle tumors: Surgical strategies according to tumor origin and development—A series of 72 cases. Neurosurgery 56:36–45. https://doi.org/10.1227/01.neu.0000333772.35822.37
doi: 10.1227/01.neu.0000333772.35822.37 pubmed: 15799791
Konovalov A, Maryashev S, Pitskhelauri D, Siomin V, Golanov A, Dalechina A (2021) The last decade’s experience of management of central neurocytomas: treatment strategies and new options. Surg Neurol Int 12:336. https://doi.org/10.25259/SNI_764_2020
doi: 10.25259/SNI_764_2020 pubmed: 34345477 pmcid: 8326110
Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70(1):41–55. https://doi.org/10.1093/biomet/70.1.41
doi: 10.1093/biomet/70.1.41
Konovalov A, Maryashev S, Pitskhelauri D, Siomin V, Golanov A, Dalechina A (2021) The last decade’s experience of management of central neurocytomas: treatment strategies and new options. Surg Neurol Int 12:336. https://doi.org/10.25259/SNI_764_2020 PMID: 34345477; PMCID: PMC8326110
doi: 10.25259/SNI_764_2020 pubmed: 34345477 pmcid: 8326110
Imber BS, Braunstein SE, Wu FY, Nabavizadeh N, Boehling N, Weinberg VK et al (2016) Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience. J Neurooncol 126(1):193–200. https://doi.org/10.1007/s11060-015-1959
doi: 10.1007/s11060-015-1959 pubmed: 26493740 pmcid: 4826306
Varma A, Giraldi D, Mills S, Brodbelt AR, Jenkinson MD (2018) Surgical management and long-term outcome of intracranial subependymoma. Acta Neurochir 160(9):1793–1799. https://doi.org/10.1007/s00701-018-3570-4
doi: 10.1007/s00701-018-3570-4 pubmed: 29915887
Chai YH, Jung S, Lee JK, Kim IY, Jang WY, Moon KS et al (2017) Ependymomas: prognostic factors and outcome analysis in a retrospective series of 33 patients. Brain Tumor Res Treat 5(2):70–76. https://doi.org/10.14791/btrt.2017.5.2.70
doi: 10.14791/btrt.2017.5.2.70 pubmed: 29188207 pmcid: 5700030
Kim JW, Kim DG, Kim IK, Kim YH, Choi SH, Han JH, Park CK, Chung HT, Park SH, Paek SH, Jung HW (2013) Central neurocytoma: long-term outcomes of multimodal treatments and management strategies based on 30 years’ experience in a single institute. Neurosurgery 72(3):407–413. https://doi.org/10.1227/NEU.0b013e3182804662
doi: 10.1227/NEU.0b013e3182804662 pubmed: 23208055
Chen LF, Yang Y, Ma XD, Yu XG, Xu BN, Zhou DB (n.d.). Operative management of intraventricular central neurocytomas: an analysis of a surgical experience with 32 cases

Auteurs

S A Maryashev (SA)

Department of Neurosurgery, N. N. Burdenko National Medical Research Center of Neurosurgery, Moscow, Russia. smaryashev@gmail.com.

G V Danilov (GV)

Department of Medical Statistics, N. N. Burdenko National Medical Research Center of Neurosurgery, Moscow, Russia.

U V Strunina (UV)

Department of Medical Statistics, N. N. Burdenko National Medical Research Center of Neurosurgery, Moscow, Russia.

V E Siomin (VE)

Department of Neurosurgery, Miami Neuroscience Institute, Baptist Hospital of Miami, Miami, FL, USA.

A I Batalov (AI)

Department of Neuroradiology, N. N. Burdenko National Medical Research Center of Neurosurgery, Moscow, Russia.

A V Dalechina (AV)

National Research Nuclear University Mephi, Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH